Factors affecting gentamicin penetration in lower extremity ischemic tissues with ulcers

International Journal of Lower Extremity Wounds

Volumn 10, Issue 3, 2011, Pages 130-137

  Zammit, Marie Clare ^a   Fiorentino, Lara ^a   Cassar, Kevin ^a   Azzopardi, Lilian M ^a   Laferla, Godfrey ^a  

^a UNIVERSITY OF MALTA   (Malta)

Author keywords

diabetic foot infections; gentamicin; ischemia; peripheral arterial disease; tissue distribution

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN;

ADULT; AGED; AMPUTATION; ANTIBIOTIC THERAPY; ARTICLE; DEBRIDEMENT; DIABETIC FOOT; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG PENETRATION; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOOT ULCER; HUMAN; INFECTION; LEG ISCHEMIA; LEG ULCER; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SKELETAL MUSCLE; SUBCUTANEOUS TISSUE; TISSUE DISTRIBUTION; TREATMENT OUTCOME; WOUND CARE;

ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; ANTI-BACTERIAL AGENTS; DEBRIDEMENT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENTAMICINS; HUMANS; ISCHEMIA; LEG; LEG ULCER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PERIPHERAL ARTERIAL DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 80052857309     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734611418571     Document Type: Article

References (35)

1. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003 ; 26: 3333-3341
2. Schaffer M, Witte M, Becker HD. Models to study ischemia in chronic wounds. Int J Low Extrem Wounds. 2002 ; 1: 104-111
3. Finberg RW, Moellering RC, Tally FP, et al. The importance of bactericidal drugs: future direction in infectious disease. Clin Infect Dis. 2004 ; 39: 1314-1320 (Pubitemid 39458517)
4. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998 ; 26: 1-12 (Pubitemid 28068148)
5. Burgess DS. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance. Chest. 1999 ; 115 (1 suppl). 19S - 23S (Pubitemid 29133432)
6. Panidis D, Markantonis SL, Boutzouka E, Karatzas S, Baltopoulos G. Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia. Chest. 2005 ; 128: 545-552 (Pubitemid 41140478)
7. Garcia B, Barcia E, Perez F, Molina IT. Population pharmacokinetics of gentamicin in premature newborns. J Antimicrob Chemother. 2006 ; 58: 372-379 (Pubitemid 44294950)
8. Lecaroz C, Campanero MA, Gamazo C, Blanco-Prieto MJ. Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method. J Antimicrob Chemother. 2006 ; 58: 557-563 (Pubitemid 44288119)
9. Al-Lanqawi Y, Capps P, Abdel-Hamid M, et al. Therapeutic drug monitoring of gentamicin: Evaluation of five nomograms for initial dosing at Al-Amiri Hospital in Kuwait. Med Princ Pract. 2007 ; 16: 348-354 (Pubitemid 47294489)
10. Francetic I, Kalenic S, Huic M, et al. Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal intervention study. Croat Med J. 2008 ; 49: 207-214 (Pubitemid 351669461)
11. Hauschild T, Sacha P, Wieczorek P, Zalewska M, Kaczynska K, Tryniszewska E. Aminoglycosides resistance in clinical isolates of Staphylococcus aureus from a university hospital in Bialystok, Poland. Folia Histochem Cytobiol. 2008 ; 46: 225-228
12. Jolley ME, Stroupe SD, Schwenzer KS, et al. Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma. Clin Chem. 1981 ; 27: 1190-1197 (Pubitemid 11071857)
13. Burkhardt O, Brunner M, Schmidt S, Grant M, Tang Y, Derendorf H. Penetration of ertapnem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis. J Antimicrob Chemother. 2006 ; 58: 632-636 (Pubitemid 44288130)
14. Muller-Serieys C, Soler P, Cantalloube C, et al. Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647). Antimicrob Agents Chemother. 2001 ; 45: 3104-3108 (Pubitemid 32988835)
15. Boselli E, Breilh D, Djabarouti S, Bel JC, Saux MC, Allaouchiche B. Diffusion of ertapenem into bone and synovial tissues. J Antimicrob Chemother. 2007 ; 60: 893-896 (Pubitemid 47434274)
16. Kuck EM, Bouter KP, Hoekstra JBL, Conemans JM, Diepersloot RJ. Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections. Foot Ankle Int. 1998 ; 19: 38-40 (Pubitemid 28065163)
17. Oberdorfer K, Swoboda S, Hamann A, et al. Tissue and serum levofloxacin concentrations in diabetic foot infection patients. J Antimicrob Chemother. 2004 ; 54: 836-839 (Pubitemid 39386742)
18. Stein GE, Schooley S, Peloquin CA, Missavage A, Havlichek DH. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections. J Antimicrob Chemother. 2007 ; 60: 819-823 (Pubitemid 47434261)
19. Dehghanyar P, Burger C, Zeitlinger M, et al. Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses. Antimicrob Agents Chemother. 2005 ; 49: 2367-2371 (Pubitemid 40734468)
20. Buerger C, Plock N, Dehghanyar P, Joukhadar C, Kloft C. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis. Antimicrob Agents Chemother. 2006 ; 50: 2455-2463 (Pubitemid 43993186)
21. Lorentzen H, Kallehave F, Kolmos HJ, Knigge U, Bulow J, Gottrup F. Gentamicin concentrations in human subcutaneous tissue. Antimicrob Agents Chemother. 1996 ; 40: 1785-1789 (Pubitemid 26277793)
22. Verpooten GA, Giuliano RA, Verbist L, Eestermans G, De Broe ME. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin Pharmacol Ther. 1989 ; 45: 22-27 (Pubitemid 19047142)
23. Gill MA, Cohen JL, Chenella FC, et al. Gentamicin penetration into diseased appendix tissue. Ther Drug Monit. 1984 ; 6: 298-301 (Pubitemid 14037120)
24. Fiscella RG, Gieser J, Phillpotts B, et al. Intraocular penetration of gentamicin after once-daily aminoglycoside dosing. Retina. 1998 ; 18: 339-342 (Pubitemid 30387105)
25. Müller M, de la Pena A, Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob Agents Chemother. 2004 ; 48: 1441-1453 (Pubitemid 38544345)
26. Zaske DE, Cipolle RJ, Rotschafer JC, Solem LD, Mosier NR, Strate RG. Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations. Antimicrob Agents Chemother. 1982 ; 21: 407-411 (Pubitemid 12117784)
27. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintilliani R. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995 ; 39: 650-655
28. Romano S, Gonzalez P, Tejada P, Anton J, Aguado JM, Lanao JM. Influence of diagnostic and treatment factors in the population pharmacokinetics of gentamicin. J Clin Pharm Ther. 1998 ; 23: 141-148 (Pubitemid 28464382)
29. Bartal C, Danon A, Schlaeffer F, et al. Pharmacokinetic dosing of aminoglycosides: a controlled trial. Am J Med. 2003 ; 114: 194-198 (Pubitemid 36294004)
30. Xuan D, Nicolau DP, Nightingale CH. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing. Int J Antimicrob Agents. 2004 ; 23: 291-295 (Pubitemid 38283599)
31. Edmonds ME, Foster AVM. Diabetic foot ulcers. BMJ. 2006 ; 332: 407-410 (Pubitemid 43797386)
32. Brown SA, Sugimoto K, Smith GG, Garry FB. Improved sodium hydroxide digestion method without homogenization for the extraction of gentamicin from renal tissue. Antimicrob Agents Chemother. 1988 ; 32: 595-597 (Pubitemid 18089374)
33. Brown SA, Newkirk DR, Hunter R, Smith GG, Sugimoto K. Extraction methods for quantitation of gentamicin residues from tissues using fluorescence polarization immunoassay. J Assoc Off Anal Chem. 1990 ; 73: 479-483
34. International Conference on Harmonisation. Validation of analytical procedures: text and methodology: Q2(R1). ICH 2005. http://www.ich.org/products/ guidelines/quality/article/quality-guidelines.html. Accessed March 21, 2011.
35. Food and Drug Administration. Guidance for industry: bioanalytical method validation. FDA 2001. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf. Published May 2001. Accessed March 21, 2011.